2:30 – 3:30 pm Friday, September 4

How to Return Research Results to Patients and Families? The Children’s Oncology Group Experience (C232)

coglogoIn North America, the majority of children with cancer will enroll in a clinical trial at some point during their treatment. Clinical research is rooted in the premise that the quantity and quality of human lives will be improved by carefully conducted clinical and basic research.

Read more...
Speaker:
Kimberly Pyke-Grimm, PhD RN CNS CPHON®
CNE Hours
1
3:10–3:30 pm Friday, September 4

Paper Presentation: Symptom Reporting Strategies—Patient and Parent Experiences of Cancer Symptoms as Assessed by the Memorial Symptom Assessment Scale for Children (231-3)

Treatment for childhood cancer is associated with symptoms that contribute to poorer psychological and physical functioning and decreased quality of life. Symptom assessment scales have been used to identify the prevalence, severity, and distress related to cancer treatment.

Read more...
Speaker:
Melody Hellsten, DNP APRN PPCNP-BC CHPPN
CNE Hours
0.34
2:30 – 3:30 pm Friday, September 4

Below the Surface:  Applying Evidence-Based Practice in Skin Care Management with the Hematopoietic Cell Transplant Patient (229)

Children and adolescents undergoing hematopoietic cell transplant (HCT) are at high risk for developing skin complications. Nurses play a vital role in the assessment, prevention, and management of skin issues in this population where multiple factors lead to skin complications.

Read more...
Speaker:

Nancy Noonan, MS RN PCNS-BC BMTCN®

Linda Abramovitz, MSN RN CNS FAAN BMTCN®

Lisa Pinner, RN MSN CNS BMTCN® CPON® 

CNE Hours
1
12:15 – 1:15 pm Friday, September 4

High Risk Neuroblastoma in the new decade: Incorporating targeted therapies to maximize impact in current Children’s Oncology Group trials (C226)

coglogoWhile the overall cure rate for childhood cancer is approaching 80%, the prognosis for long-term survival for children with high risk neuroblastoma lags considerably behind, at 50%–60%. Upfront standard treatment for high-risk neuroblastoma protocols within the Children’s Oncology Group (COG) has historically utilized all available modalities of cancer treatment including chemotherapy, surgery, myeloablative chemotherapy with stem cell rescue, radiation therapy, differentiating agents, and most recently biologic therapy with anti-GD2 antibody (dinutuximab) used post consolidation in ANBL0032.

Read more...
Speaker:

Wendy Fitzgerald, MSN APRN PPCNP-BC

Denise Mills, MN RN(EC) NP CPHON®

CNE Hours
1
2:30 – 3:30 pm Thursday, September 3

Reproductive Health: from Diagnosis through Survivorship – Resources and Perspectives from the Children’s Oncology Group (C221)

coglogoPuberty and sexual and reproductive health are normal parts of human growth and development. Adolescence and young adulthood are developmental times of exploration of sexual identity and planning for the future, which may include parenting goals. A cancer diagnosis does not preclude a patient or their family from concern about sexual and reproductive health.

Read more...
Speaker:
Brooke Cherven, PhD MPH RN CPON®
Barbara Lockart, DNP APRN PC & AC CPHON®
CNE Hours
1
2:10 – 3:30 pm Thursday, September 3

Paper Presentation: Global Health—Long-Distance Coaching for a Quality Improvement Initiative to Improve Nursing Assessment and Management of Nausea and Vomiting in Marrakech, Morocco (220-3)

Quality improvement (QI) in health care consists of systematic and continuous actions that lead to measurable improvements in the patient experience. While QI methodology has long been included as a core component of nursing education and professional development in institutions in the United States, QI methodology is novel in many low- and middle-income countries.

Read more...
Speaker:
Elizabeth Sniderman, MSN APRN CPNP-AC CPHON®
CNE Hours
0.34
2:30 – 3:30 pm Thursday, September 3

Marijuana, Hemp, and the Child with Cancer (217)

Many pediatric oncology patients report medical marijuana (MMJ) and hemp-based CBD use. Over 4,000 children are registered users of marijuana in Colorado, the first state to legalize recreational marijuana. Eleven states and Washington, DC have legalized marijuana for recreational use for adults older than 21.

Read more...
Speaker:
Molly Hemenway, DNP MS AC/PC-CPNP
CNE Hours
1
12:15 – 1:15 pm Thursday, September 3

Cancer Control and Supportive Care in the Children’s Oncology Group: Nursing Roles and Recent Results (C215)

coglogoSurvival rates for many pediatric cancers have improved over time, although children and adolescents continue to experience acute and delayed toxicities related to their disease and treatment. This session will review the purpose and research domains within the Children’s Oncology Group (COG) Cancer Control (CCL) Committee.

Read more...
Speaker:
Jessica Ward, PhD MPH RN CPNP
Melissa Beauchemin, PhD RN CPNP CPON®
CNE Hours
1
12:55 – 1:15 pm Thursday, September 3

Paper Presentation: Supporting Patient Well-Being and Quality of Life—Psychosocial interventions to improve social health of adolescents and young adults with cancer: A review (214-3)

The incidence of cancer diagnosis in the adolescent and young adult (AYA) population has been increasing, and more frequently these patients are being cared for at pediatric institutions. The AYA population has a set of psychosocial needs that differ from other age groups. Failure to tend to these needs leads to a host of negative health outcomes from cancer and therapy and negatively impacts the quality of life.

Read more...
Speaker:
Clifton Thornton, MSN RN CNMT CPNP
CNE Hours
0.34
Subscribe to this RSS feed